Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation A...

por Hsu, Ping-Chih, Li, Jhy-Ming, Yang, Cheng-Ta
Publicado 2022

The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer

por Hsu, Ping-Chih, Yang, Cheng-Ta, Jablons, David M., You, Liang
Publicado 2018

Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

por Hsu, Ping-Chih, Jablons, David M., Yang, Cheng-Ta, You, Liang
Publicado 2019

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)

por Hsu, Ping-Chih, Yang, Cheng-Ta, Jablons, David M., You, Liang
Publicado 2020

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case...

por Hsu, Ping-Chih, Chen, Tai-Di, Tsai, Tsung-Yu, Yang, Cheng-Ta
Publicado 2023

Nuclear p120 catenin is a component of the perichromosomal layer and coordinates sister chromatid segregation during mitosis in lung cancer cells

por Chow, Shu-Er, Meir, Yaa-Jyuhn J., Li, Jhy-Ming, Hsu, Ping-Chih, Yang, Cheng-Ta
Publicado 2022

Comparison of Efficacy of 2% Chlorhexidine Gluconate–Alcohol and 10% Povidone-Iodine–Alcohol against Catheter-Related Bloodstream Infections and Bacterial Colonization at Central V...

por Lin, Ming-Ru, Chang, Po-Jui, Hsu, Ping-Chih, Lin, Chun-Sui, Chiu, Cheng-Hsun, Chen, Chih-Jung
Publicado 2022

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)

por Chiu, Li-Chung, Lin, Shu-Min, Lo, Yu-Lun, Kuo, Scott Chih-Hsi, Yang, Cheng-Ta, Hsu, Ping-Chih
Publicado 2021

Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study

por Wang, Chin-Chou, Chiu, Li-Chung, Ju, Jia-Shiuan, Lin, Yu-Ching, Fang, Yueh-Fu, Yang, Cheng-Ta, Hsu, Ping-Chih
Publicado 2021

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

por Wu, Chiao-En, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Chang, John Wen-Cheng
Publicado 2021

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

por Wu, Chiao-En, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Chang, John Wen-Cheng
Publicado 2022

Cucurbitacin E inhibits the Yes-associated protein signaling pathway and suppresses brain metastasis of human non-small cell lung cancer in a murine model

por Hsu, Ping-Chih, Tian, Bo, Yang, Yi-Lin, Wang, Yu-Cheng, Liu, Shu, Urisman, Anatoly, Yang, Cheng-Ta, Xu, Zhidong, Jablons, David M., You, Liang
Publicado 2019

Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma

por Yang, Yi-Lin, Ni, Jian, Hsu, Ping-Chih, Mao, Jian-Hua, Hsieh, David, Xu, Angela, Chan, Geraldine, Au, Alfred, Xu, Zhidong, Jablons, David M, You, Liang
Publicado 2015

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma

por Hsu, Ping-Chih, Wang, Chih-Wei, Kuo, Scott Chih-Hsi, Lin, Shu-Min, Lo, Yu-Lun, Huang, Allen Chung-Cheng, Chiu, Li-Chung, Yang, Cheng-Ta
Publicado 2020

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

por Chang, John Wen-Cheng, Huang, Chen-Yang, Fang, Yueh-Fu, Chang, Ching-Fu, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Wu, Chiao-En
Publicado 2022

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

por Chang, John Wen‐Cheng, Huang, Chen‐Yang, Fang, Yueh‐Fu, Chang, Ching‐Fu, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Hsu, Ping‐Chih, Wu, Chiao‐En
Publicado 2022

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

por Hsu, Ping-Chih, Chang, John Wen-Cheng, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Fang, Yueh-Fu, Wu, Chiao-En
Publicado 2022

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

por Chang, John Wen‐Cheng, Huang, Chen‐Yang, Fang, Yueh‐Fu, Chang, Ching‐Fu, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Hsu, Ping‐Chih, Wu, Chiao‐En
Publicado 2022

The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer

por Chang, John Wen‐Cheng, Chang, Ching‐Fu, Huang, Chen‐Yang, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Fang, Yueh‐Fu, Hsu, Ping‐Chih, Wu, Chiao‐En
Publicado 2022

YAP regulates PD-L1 expression in human NSCLC cells

por Miao, Jinbai, Hsu, Ping-Chih, Yang, Yi-Lin, Xu, Zhidong, Dai, Yuyuan, Wang, Yucheng, Chan, Geraldine, Huang, Zhen, Hu, Bin, Li, Hui, Jablons, David M., You, Liang
Publicado 2017